The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Percutaneous Injection of Autologous Bone Marrow Concentrate Cells Significantly Reduces Lumbar Discogenic Pain Through 12 Months
Abstract
Degenerative disc disease (DDD) induces chronic back pain with limited nonsurgical options. In this open label pilot study, 26 patients (median age 40 years; range 18–61) received autologous bone marrow concentrate (BMC) disc injections (13 one level, 13 two levels). Pretreatment Oswestry disability index (ODI) and visual analog scale (VAS) were performed to establish baseline pain scores (average 56.5 and 79.3, respectively), while magnetic resonance imaging was independently scored according to the modified Pfirrmann scale. Approximately 1 ml of BMC was analyzed for total nucleated cell (TNC) content, colony-forming unit-fibroblast (CFU-F) frequency, differentiation potential, and phenotype characterization. The average ODI and VAS scores were reduced to 22.8 and 29.2 at 3 months, 24.4 and 26.3 at 6 months, and 25.0 and 33.2 at 12 months, respectively (p ≤ .0001). Eight of twenty patients improved by one modified Pfirrmann grade at 1 year. The average BMC contained 121 × 106 TNC/ml with 2,713 CFU-F/ml (synonymous with mesenchymal stem cells). Although all subjects presented a substantial reduction in pain, patients receiving greater than 2,000 CFU-F/ml experienced a significantly faster and greater reduction in ODI and VAS. Subjects older than 40 years who received fewer than 2,000 CFU-F/ml experienced an average pain reduction of 33.7% (ODI) and 29.1% (VAS) at 12 months, while all other patients' average reduction was 69.5% (ODI, p = .03) and 70.6% (VAS, p = .01). This study provides evidence of safety and feasibility in the nonsurgical treatment of DDD with autologous BMC and indicates an effect of mesenchymal cell concentration on discogenic pain reduction. Stem Cells 2015;33:146–156
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370
Overtreating chronic back pain: time to back off?
Deyo, R. A., Mirza, S. K., Turner, J. A., & Martin, B. I. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.01.080102 · Cited by 796
Brox, J. I., Reikerås, O., Nygaard, Y., Srensen, R., Indahl, A., Holm, I., Keller, A., Ingebrigtsen, T., Grundnes, O., Lange, J. E., et al. (2006) · Pain · doi:10.1016/j.pain.2006.01.027 · Cited by 296
Cited by
Inflammation in intervertebral disc degeneration and regeneration
Molinos, M., Almeida, C. R., Caldeira, J., Cunha, C., Gonçalves, R. M., & Barbosa, M. A. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.1191 · Cited by 454
A comparison of different bioinks for 3D bioprinting of fibrocartilage and hyaline cartilage
Daly, A. C., Critchley, S. E., Rencsok, E. M., & Kelly, D. J. (2016) · Biofabrication · doi:10.1088/1758-5090/8/4/045002 · Cited by 436
Cell-based strategies for IVD repair: clinical progress and translational obstacles
Binch, A. L. A., Fitzgerald, J. C., Growney, E. A., & Barry, F. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00568-w · Cited by 296
Metadata
- Authors
- Pettine, K. A., Murphy, M. B., Suzuki, R. K., & Sand, T. T.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-12-18
- Volume
- 33
- Issue
- 1
- Pages
- 146-156
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W1531471675
- Cited by
- 201
- References
- 3
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Percutaneous Injection of Autologous Bone Marrow Concentrate Cells Significantly Reduces Lumbar Discogenic Pain Through 12 Months. https://app.cochat.ai/papers/10.1002/stem.1845
- The paper
- Pettine, K. A., Murphy, M. B., Suzuki, R. K., & Sand, T. T. (2015). Percutaneous Injection of Autologous Bone Marrow Concentrate Cells Significantly Reduces Lumbar Discogenic Pain Through 12 Months. Stem Cells. https://doi.org/10.1002/stem.1845
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.